Angiogenesis
Research Areas
Products Related to Angiogenesis(378)
- GC465833-Amino-2,6-PiperidinedioneCAS: 2353-44-8Purity: >95.00%
An active metabolite of (±)-thalidomide
- GC46899Axitinib-13C-d3CAS: 1261432-00-1Purity: >99.00%
An internal standard for the quantification of axitinib
- GC46986C18 Ceramide-1-phosphate-d3 (d18:1/18:0-d3)CAS: 2692624-25-0Purity: >99.00%
A neuropeptide with diverse biological activities
- GC47234Diosmetin-d3CAS: 1189728-54-8Purity: >99.00%
An internal standard for the quantification of diosmetin
- GC47328Everolimus-d4CAS: 1338452-54-2Purity: >99.00%
An internal standard for the quantification of everolimus
- GC47398Genistein-d4CAS: 187960-08-3Purity: >99.00%
An internal standard for the quantification of genistein
- GC47965Pomalidomide-d5CAS: 1377838-49-7Purity: >99.00%
An internal standard for the quantification of pomalidomide
- GC47980Propionyl-L-carnitine-d3 (chloride)CAS: 1334532-19-2Purity: >99.00%
An internal standard for the quantification of propionyl-L-carnitine
- GC48078Sildenafil-d3CAS: 1126745-90-1Purity: >99.50%
An internal standard for the quantification of sildenafil
- GC48195trans-trismethoxy Resveratrol-d4CAS: 1089051-64-8Purity: >99.00%
An internal standard for the quantification of trans-trismethoxy resveratrol
- GC49358Sildenafil ChlorosulfonylCAS: 139756-22-2Purity: >98.00%
An intermediate in the synthesis of sildenafil
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC46583 | 3-Amino-2,6-Piperidinedione | 2353-44-8 | >95.00% | |
An active metabolite of (±)-thalidomide | ||||
| GC46899 | Axitinib-13C-d3 | 1261432-00-1 | >99.00% | |
An internal standard for the quantification of axitinib | ||||
| GC46924 | BIBF 1120-13C-d3 | - | >99.00% | |
A neuropeptide with diverse biological activities | ||||
| GC46986 | C18 Ceramide-1-phosphate-d3 (d18:1/18:0-d3) | 2692624-25-0 | >99.00% | |
A neuropeptide with diverse biological activities | ||||
| GC47163 | D-2-Aminoglutarimide (hydrochloride) | 1801140-47-5 | >95.00% | |
A synthetic intermediate | ||||
| GC47234 | Diosmetin-d3 | 1189728-54-8 | >99.00% | |
An internal standard for the quantification of diosmetin | ||||
| GC47298 | Epalrestat-d5 | - | >99.00% | |
A neuropeptide with diverse biological activities | ||||
| GC47328 | Everolimus-d4 | 1338452-54-2 | >99.00% | |
An internal standard for the quantification of everolimus | ||||
| GC47398 | Genistein-d4 | 187960-08-3 | >99.00% | |
An internal standard for the quantification of genistein | ||||
| GC47454 | IMS 2186 | 1031206-36-6 | >98.00% | |
An anti-choroidal neovascularization agent | ||||
| GC47582 | Lupulone | 468-28-0 | >95.00% | |
A beta-acid | ||||
| GC47965 | Pomalidomide-d5 | 1377838-49-7 | >99.00% | |
An internal standard for the quantification of pomalidomide | ||||
| GC47966 | PPACK (trifluoroacetate salt) | - | >95.00% | |
An antithrombin peptide | ||||
| GC47980 | Propionyl-L-carnitine-d3 (chloride) | 1334532-19-2 | >99.00% | |
An internal standard for the quantification of propionyl-L-carnitine | ||||
| GC48078 | Sildenafil-d3 | 1126745-90-1 | >99.50% | |
An internal standard for the quantification of sildenafil | ||||
| GC48122 | Tafluprost (free acid)-d4 | - | >99.00% | |
A neuropeptide with diverse biological activities | ||||
| GC48123 | Tafluprost-d4 | - | >99.00% | |
A neuropeptide with diverse biological activities | ||||
| GC48195 | trans-trismethoxy Resveratrol-d4 | 1089051-64-8 | >99.00% | |
An internal standard for the quantification of trans-trismethoxy resveratrol | ||||
| GC48210 | TRX-818 (sodium salt) | 1256037-62-3 | >98.00% | |
An anticancer compound | ||||
| GC48360 | WKYMVm (trifluoroacetate salt) | - | >98.00% | |
| GC49221 | QLT0267 | 866409-68-9 | >98.00% | |
An ILK inhibitor | ||||
| GC49349 | O-Desethyl Sildenafil | 139755-91-2 | >95.00% | |
A metabolite of sildenafil | ||||
| GC49358 | Sildenafil Chlorosulfonyl | 139756-22-2 | >98.00% | |
An intermediate in the synthesis of sildenafil | ||||
| GC49433 | Capsiate | 205687-01-0 | >85.00% | |
A capsaicin analog with diverse biological activities | ||||